GNFT - Genfit SA

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
+0.12 (+0.48%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close24.86
Bid24.84 x 900
Ask24.84 x 800
Day's Range24.29 - 24.98
52 Week Range20.81 - 26.08
Avg. Volume360,211
Market Cap965.502M
Beta (3Y Monthly)1.22
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Gilead to Collaborate with Novo Nordisk for NASH Treatment
    Zacks5 days ago

    Gilead to Collaborate with Novo Nordisk for NASH Treatment

    Gilead Sciences (GILD) will collaborate with Novo Nordisk to develop treatments for liver disease, NASH.

  • 3 Top Small-Cap Biotech Stocks for Aggressive Investors
    Motley Fool13 days ago

    3 Top Small-Cap Biotech Stocks for Aggressive Investors

    They're risky, but these up-and-coming biotechs could be tremendous winners for investors willing to take on those risks.

  • GuruFocus.com18 days ago

    5 IPOs Doing Better Than Lyft in 2019

    Each company to debut this year has gained, except the ride-hailing startup

  • GlobeNewswire24 days ago

    Nasdaq Welcomes GENFIT S.A. (Nasdaq: GNFT) to The Nasdaq Stock Market

    GENFIT S.A. (GNFT), a late-stage clinical biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting liver diseases, in particular those of metabolic origin, rang the Nasdaq MarketSite bell in Times Square today in celebration of its initial public offering on The Nasdaq Stock Market. GENFIT is a leader in the field of nuclear receptor-based drug discovery with a rich history and strong scientific heritage spanning almost two decades.

  • Benzinga27 days ago

    IPO Outlook For The Week: Biopharm, Gene Editor And Lyft

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . IPO dates below are expected but not confirmed. Genfit S.A. (GNFT) will issue 5 million shares at $26.33 each Wednesday ...